EXACT SCIENCES CORP Payment for Contingent Consideration Liability, Investing Activities
EXACT SCIENCES CORP reported Payment for Contingent Consideration Liability, Investing Activities of $3.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities · last filed 2025-02-19
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for the quarter ending 2024-09-30 was $0.00.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for the quarter ending 2023-12-31 was $127.00K.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for the quarter ending 2023-09-30 was $0.00.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for fiscal 2024 was $3.10M, a 1271.68% increase from fiscal 2023.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for fiscal 2023 was $226.00K, a 193.51% increase from fiscal 2022.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for fiscal 2022 was $77.00K, a 52.76% decline from fiscal 2021.
- EXACT SCIENCES CORP payment for contingent consideration liability, investing activities for fiscal 2021 was $163.00K, a 111.69% increase from fiscal 2020.
| Period end | Payment for Contingent Consideration Liability, Investing Activities 3 month | Payment for Contingent Consideration Liability, Investing Activities 6 month | Payment for Contingent Consideration Liability, Investing Activities 9 month | Payment for Contingent Consideration Liability, Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $0.00 derived: sum of 2 quarters · filed 2025-02-19 | $3.10M 10-K · filed 2025-02-19 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 | $3.10M 10-Q · filed 2024-11-05 | ||
| 2024-06-30 | $3.10M 10-Q · filed 2024-07-31 | |||
| 2023-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $127.00K derived: sum of 2 quarters · filed 2025-02-19 | $226.00K 10-K · filed 2025-02-19 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-05 | $99.00K 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $99.00K 10-Q · filed 2023-08-01 | |||
| 2022-12-31 | $77.00K 10-K · filed 2025-02-19 | |||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$1.00K derived: sum of 2 quarters · filed 2023-02-21 | -$1.00K derived: sum of 3 quarters · filed 2023-02-21 | $163.00K 10-K · filed 2023-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $164.00K 10-Q · filed 2021-11-02 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $164.00K 10-Q · filed 2021-07-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | -$87.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-03-31 | $164.00K 10-Q · filed 2021-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | -$87.00K derived: sum of 3 quarters · filed 2022-02-22 | $101.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-12-31 | -$164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$251.00K derived: sum of 2 quarters · filed 2022-02-22 | -$63.00K derived: sum of 3 quarters · filed 2022-02-22 | $77.00K 10-K · filed 2022-02-22 |
| 2020-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $101.00K derived: sum of 2 quarters · filed 2020-10-27 | $241.00K 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $328.00K 10-Q · filed 2020-07-31 | ||
| 2020-03-31 | $140.00K 10-Q · filed 2021-05-04 |